Literature DB >> 17159070

Aldosterone and cardiovascular disease: smoke and fire.

David A Calhoun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17159070     DOI： 10.1161/CIRCULATIONAHA.106.668715

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

Review 1.  Eplerenone: a review of its use in patients with chronic systolic heart failure and mild symptoms.

Authors:  Sohita Dhillon
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

2.  Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension.

Authors:  D Walter Wray; Mark A Supiano
Journal:  Hypertension       Date:  2010-04-05       Impact factor: 10.190

3.  Endothelial metabolism of angiotensin II to angiotensin III, not angiotensin (1-7), augments the vasorelaxation response in adrenal cortical arteries.

Authors:  Phillip G Kopf; William B Campbell
Journal:  Endocrinology       Date:  2013-10-03       Impact factor: 4.736

4.  Angiotensin II-activated protein kinase D mediates acute aldosterone secretion.

Authors:  Brian A Shapiro; Lawrence Olala; Senthil Nathan Arun; Peter M Parker; Mariya V George; Wendy B Bollag
Journal:  Mol Cell Endocrinol       Date:  2009-12-02       Impact factor: 4.102

5.  Angiotensin II-induced protein kinase D activates the ATF/CREB family of transcription factors and promotes StAR mRNA expression.

Authors:  Lawrence O Olala; Vivek Choudhary; Maribeth H Johnson; Wendy B Bollag
Journal:  Endocrinology       Date:  2014-04-07       Impact factor: 4.736

Review 6.  Epigenetic modification: a regulatory mechanism in essential hypertension.

Authors:  Mohammed Arif; Sakthivel Sadayappan; Richard C Becker; Lisa J Martin; Elaine M Urbina
Journal:  Hypertens Res       Date:  2019-03-13       Impact factor: 3.872

7.  Effect and mechanism of poly (ADP-ribose) polymerase-1 in aldosterone-induced apoptosis.

Authors:  Weiwei Qiao; Weili Zhang; Shuhong Shao; Yusheng Gai; Mingxiang Zhang
Journal:  Mol Med Rep       Date:  2015-04-07       Impact factor: 2.952

8.  Effects of Vitamin D Supplementation on Plasma Aldosterone and Renin-A Randomized Placebo-Controlled Trial.

Authors:  Martin R Grübler; Martin Gaksch; Katharina Kienreich; Nicolas Verheyen; Johannes Schmid; Bríain W J Ó Hartaigh; Georg Richtig; Hubert Scharnagl; Andreas Meinitzer; Burkert Pieske; Astrid Fahrleitner-Pammer; Winfried März; Andreas Tomaschitz; Stefan Pilz
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-04-21       Impact factor: 3.738

9.  Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population.

Authors:  Valentina Cannone; Alessia Buglioni; S Jeson Sangaralingham; Christopher Scott; Kent R Bailey; Richard Rodeheffer; Margaret M Redfield; Riccardo Sarzani; John C Burnett
Journal:  Mayo Clin Proc       Date:  2018-08       Impact factor: 11.104

10.  Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO/GC signaling.

Authors:  Marcondes A B Silva; Thiago Bruder-Nascimento; Stefany B A Cau; Rheure A M Lopes; Fabiola L A C Mestriner; Rafael S Fais; Rhian M Touyz; Rita C Tostes
Journal:  Front Physiol       Date:  2015-10-05       Impact factor: 4.566
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.